268 related articles for article (PubMed ID: 33252175)
1. The promises and challenges of early non-small cell lung cancer detection: patient perceptions, low-dose CT screening, bronchoscopy and biomarkers.
Kalinke L; Thakrar R; Janes SM
Mol Oncol; 2021 Oct; 15(10):2544-2564. PubMed ID: 33252175
[TBL] [Abstract][Full Text] [Related]
2. Advances in lung cancer screening and early detection.
Li C; Wang H; Jiang Y; Fu W; Liu X; Zhong R; Cheng B; Zhu F; Xiang Y; He J; Liang W
Cancer Biol Med; 2022 May; 19(5):591-608. PubMed ID: 35535966
[TBL] [Abstract][Full Text] [Related]
3. Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.
Robles AI; Harris CC
Lung Cancer; 2017 May; 107():50-58. PubMed ID: 27344275
[TBL] [Abstract][Full Text] [Related]
4. The Journey for Lung Cancer Screening where we Stand Today.
Wahla AS; Zoumot Z; Uzbeck M; Mallat J; Souilamas R; Shafiq I
Open Respir Med J; 2022; 16():e187430642207060. PubMed ID: 37273952
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer screening: history, current perspectives, and future directions.
Sharma D; Newman TG; Aronow WS
Arch Med Sci; 2015 Oct; 11(5):1033-43. PubMed ID: 26528348
[TBL] [Abstract][Full Text] [Related]
6. Screening approaches for lung cancer by blood-based biomarkers: Challenges and opportunities.
van den Broek D; Groen HJM
Tumour Biol; 2024; 46(s1):S65-S80. PubMed ID: 37393461
[TBL] [Abstract][Full Text] [Related]
7. Biomarker-Based Lung Cancer Screening Eligibility: Implementation Considerations.
Hung RJ
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):698-701. PubMed ID: 35373266
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer screening: what we can learn from UKLS?
Ruparel M; Janes SM
Thorax; 2016 Feb; 71(2):103-4. PubMed ID: 26769013
[No Abstract] [Full Text] [Related]
9. Impact of CT screening in lung cancer: Scientific evidence and literature review.
Kennedy K; Hulbert A; Pasquinelli M; Feldman LE
Semin Oncol; 2022 Aug; ():. PubMed ID: 36114033
[TBL] [Abstract][Full Text] [Related]
10. Emerging Strategies in Lung Cancer Screening: Blood and Beyond.
Bhalla S; Yi S; Gerber DE
Clin Chem; 2024 Jan; 70(1):60-67. PubMed ID: 38175587
[TBL] [Abstract][Full Text] [Related]
11. Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study.
Nguyen OTD; Fotopoulos I; Markaki M; Tsamardinos I; Lagani V; Røe OD
JTO Clin Res Rep; 2024 Apr; 5(4):100660. PubMed ID: 38586302
[TBL] [Abstract][Full Text] [Related]
12. Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention.
Kathuria H; Gesthalter Y; Spira A; Brody JS; Steiling K
Cancers (Basel); 2014 May; 6(2):1157-79. PubMed ID: 24840047
[TBL] [Abstract][Full Text] [Related]
13. EU Policy on Lung Cancer CT Screening 2017.
Field JK; Zulueta J; Veronesi G; Oudkerk M; Baldwin DR; Holst Pedersen J; Paci E; Horgan D; de Koning HJ
Biomed Hub; 2017; 2(Suppl 1):154-161. PubMed ID: 31988945
[TBL] [Abstract][Full Text] [Related]
14. Defining the road map to a UK national lung cancer screening programme.
O'Dowd EL; Lee RW; Akram AR; Bartlett EC; Bradley SH; Brain K; Callister MEJ; Chen Y; Devaraj A; Eccles SR; Field JK; Fox J; Grundy S; Janes SM; Ledson M; MacKean M; Mackie A; McManus KG; Murray RL; Nair A; Quaife SL; Rintoul R; Stevenson A; Summers Y; Wilkinson LS; Booton R; Baldwin DR; Crosbie P
Lancet Oncol; 2023 May; 24(5):e207-e218. PubMed ID: 37142382
[TBL] [Abstract][Full Text] [Related]
15. The use of biomarkers in the diagnosis of lung cancer.
Mlika M; Mezni F
Tunis Med; 2023 Apr; 101(4):398-403. PubMed ID: 38372537
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in Cancer Screening: Promises and Challenges in Cancer Early Detection.
Kohaar I; Hodges N; Srivastava S
Hematol Oncol Clin North Am; 2024 May; ():. PubMed ID: 38782647
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer.
Klein M; Pragman AA; Wendt C
Semin Oncol; 2022 Jul; ():. PubMed ID: 35914981
[TBL] [Abstract][Full Text] [Related]
18. The Early Diagnosis of Lung Cancer: Critical Gaps in the Discovery of Biomarkers.
Gasparri R; Sabalic A; Spaggiari L
J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068296
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies.
Etzioni R; Gulati R; Patriotis C; Rutter C; Zheng Y; Srivastava S; Feng Z
J Natl Cancer Inst; 2024 Feb; 116(2):189-193. PubMed ID: 37941446
[TBL] [Abstract][Full Text] [Related]
20. Microbes for lung cancer detection: feasibility and limitations.
Zhou S; Zhu W; Guo H; Nie Y; Sun J; Liu P; Zeng Y
Front Oncol; 2024; 14():1361879. PubMed ID: 38779090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
